Physician profile
Alyssa Lloret
NPI 1982475372
$921.80
in general payments reported to CMS, 2019-2025
9 companies · $578 in 2025
The $578 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $344 · 2025: $578.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $922.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $921.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $275.06 | 2024-2025 | Nucala |
| Genzyme Corporation | $206.02 | 2024-2025 | |
| Inspire Medical Systems, INC. | $132.74 | 2024-2025 | Inspire |
| Regeneron Healthcare Solutions, INC. | $102.18 | 2025 | Dupixent |
| Aerin Medical INC. | $98.27 | 2024-2025 | |
| Amgen INC. | $36.41 | 2025 | Tezspire |
| Hikma Pharmaceuticals USA | $30.09 | 2024 | Ryaltris |
| Phadia US INC. | $25.80 | 2024 | Immunocap |
| Cochlear Americas | $15.23 | 2025 | Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alyssa Lloret listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.